Hollow Copper Sulfide Nanoparticle-Mediated Transdermal Drug Delivery
A photothermal ablation‐enhanced transdermal drug delivery methodology is developed based on hollow copper sulfide nanoparticles (HCuSNPs) with intense photothermal coupling effects. Application of nanosecond‐pulsed near‐infrared laser allows rapid heating of the nanoparticles and instantaneous heat...
Saved in:
Published in | Small (Weinheim an der Bergstrasse, Germany) Vol. 8; no. 20; pp. 3143 - 3150 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
22.10.2012
WILEY‐VCH Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A photothermal ablation‐enhanced transdermal drug delivery methodology is developed based on hollow copper sulfide nanoparticles (HCuSNPs) with intense photothermal coupling effects. Application of nanosecond‐pulsed near‐infrared laser allows rapid heating of the nanoparticles and instantaneous heat conduction. This provides very short periods of time but extremely high temperatures in local regions, with focused thermal ablation of the stratum corneum. The depth of skin perforations can be controlled by adjusting the laser power. Skin disruption by HCuSNP‐mediated photothermal ablation significantly increases the permeability of human growth hormone. This technique offers compelling opportunities for macromolecular drug and vaccine delivery.
A transdermal delivery methodology mediated by hollow CuS nanoparticles is based on the near‐infrared (NIR) laser‐activated photothermal effect which can ablate the skin barrier, the stratum corneum. The applied nanosecond‐pulsed NIR laser provides very short periods of time but extremely high temperatures in local regions, with focused thermal ablation of the stratum corneum. This technique enables highly efficient delivery of macromolecular drugs. |
---|---|
Bibliography: | ark:/67375/WNG-KVHC301J-J istex:A8D7419CA15BEFC46C63F75D1239C41209856656 ArticleID:SMLL201200783 |
ISSN: | 1613-6810 1613-6829 |
DOI: | 10.1002/smll.201200783 |